Clearstead Advisors’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.85K Buy
506
+9
+2% +$108 ﹤0.01% 2106
2026
Q1
$2.98K Sell
497
-266
-35% -$2K ﹤0.01% 1821
2025
Q4
$5.47K Buy
763
+25
+3% +$198 ﹤0.01% 2003
2025
Q3
$7.88K Sell
738
-55
-7% -$540 ﹤0.01% 1997
2025
Q2
$7.68K Sell
793
-91
-10% -$939 ﹤0.01% 1976
2025
Q1
$13.2K Buy
884
+17
+2% +$261 ﹤0.01% 1540
2024
Q4
$12.9K Sell
867
-261
-23% -$4.25K ﹤0.01% 1510
2024
Q3
$21.6K Buy
1,128
+52
+5% +$1.08K ﹤0.01% 1394
2024
Q2
$22.3K Buy
1,076
+396
+58% +$7.87K ﹤0.01% 1348
2024
Q1
$14.2K Hold
680
﹤0.01% 1000
2023
Q4
$9.81K Sell
680
-135
-17% -$1.84K ﹤0.01% 1062
2023
Q3
$14.1K Sell
815
-159
-16% -$3.31K ﹤0.01% 941
2023
Q2
$20.3K Sell
974
-8
-0.8% -$174 ﹤0.01% 895
2023
Q1
$23.1K Sell
982
-878
-47% -$23.6K ﹤0.01% 826
2022
Q4
$52K Sell
1,860
-341
-15% -$8.72K ﹤0.01% 619
2022
Q3
$51K Sell
2,201
-692
-24% -$20.9K ﹤0.01% 602
2022
Q2
$98K Sell
2,893
-174
-6% -$6.09K 0.01% 503
2022
Q1
$107K Sell
3,067
-55
-2% -$1.88K 0.01% 535
2021
Q4
$95K Sell
3,122
-418
-12% -$13.6K 0.01% 537
2021
Q3
$116K Sell
3,540
-3,680
-51% -$118K 0.01% 457
2021
Q2
$218K Buy
+7,220
New +$238K 0.02% 331

Other funds holding OGN

Clearstead Advisors's OGN Position: Q2 2026 in Review

Clearstead Advisors increased its Organon & Co (OGN) stake by 1.8% in Q2 2026, buying an estimated $108 and bringing the position to 506 shares worth $6.85K. The position accounts for ﹤0.01% of the portfolio, ranked #2106.

Clearstead Advisors first reported a position in OGN in Q2 2021 and has held it in 21 quarters since. The position peaked at $218K in Q2 2021. 633 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Clearstead Advisors held 506 shares of Organon & Co worth $6.85K as of Q2 2026.
  • Clearstead Advisors bought 9 Organon & Co shares in Q2 2026, an estimated $108.
  • Organon & Co made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #2106 holding.
  • Clearstead Advisors first reported a position in Organon & Co in Q2 2021 and has held it in 21 quarters since.
  • Clearstead Advisors's Organon & Co position peaked at $218K in Q2 2021.
  • 633 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.